NORWAY – SpinChip Diagnostics AS, a pioneering, diagnostics company developing a next-generation point-of-care platform for in vitro diagnostics, today announced the completion of its financing round, successfully securing NOK 130 million (€13.5 million). Carnegie Investment Bank Norway acted as Sole Bookrunner on SpinChip®’s NOK 130 million (€13.5 Million) private placement. Alongside new cornerstone investors such as Kistefos AS, the financing round was also well supported by existing shareholders. The proceeds from the financing round will be used to further advance SpinChip®’s proprietary point-of-care (POC) in vitro diagnostics platform in addition…
Read MoreSpinChip successfully secures NOK 130 million (€13.5 million) in a financing round
